Considering the results obtained from urine samples, we extended the analysis of the RKIP and pRKIP to the blood samples by recruiting a new cohort of LC patients, HR-HSs, and, additionally, a group of low-risk HSs. This evidence concerns the gene PEBP1 and laryngotracheoesophageal cleft.